Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
18,675
Total Claims
$1.6M
Drug Cost
1,199
Beneficiaries
$1,344
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-97%
Opioid rate vs peers
0.1% vs 2.2% avg
-5%
Cost per patient vs peers
$1,344 vs $1,411 avg
-13%
Brand preference vs peers
9.2% vs 10.6% avg
Opioid Prescribing
0.1%
Opioid Rate
11
Opioid Claims
$49
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,704 claims · $1.3M
Generic: 16,788 claims · $337K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 145 | $237K |
| Dapagliflozin Propanediol | 74 | $107K |
| Empagliflozin | 70 | $98K |
| Apixaban | 73 | $94K |
| Dulaglutide | 37 | $82K |
| Sitagliptin Phosphate | 46 | $73K |
| Fluticasone/Umeclidin/Vilanter | 59 | $60K |
| Insulin Glargine,hum.Rec.Anlog | 52 | $44K |
| Rivaroxaban | 22 | $36K |
| Sitagliptin Phos/Metformin Hcl | 18 | $29K |
| Insulin Aspart | 24 | $24K |
| Atorvastatin Calcium | 1,804 | $23K |
| Semaglutide | 11 | $23K |
| Insulin Aspart | 17 | $23K |
| Insulin Detemir | 15 | $21K |
Prescribing Profile
Patient Profile
73
Avg Age
44%
Female
1.07
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data